- Home
- SURG vs CELU Comparison
SURG vs CELU Comparison
Compare SURG & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SURG
- CELU
- Stock Information
- Founded
- SURG 2006
- CELU 2016
- Country
- SURG United States
- CELU United States
- Employees
- SURG N/A
- CELU N/A
- Industry
- SURG Advertising
- CELU Biotechnology: Pharmaceutical Preparations
- Sector
- SURG Consumer Discretionary
- CELU Health Care
- Exchange
- SURG Nasdaq
- CELU Nasdaq
- Market Cap
- SURG 47.6M
- CELU 56.9M
- IPO Year
- SURG N/A
- CELU N/A
- Fundamental
- Price
- SURG $1.94
- CELU $2.00
- Analyst Decision
- SURG Strong Buy
- CELU Strong Buy
- Analyst Count
- SURG 1
- CELU 1
- Target Price
- SURG $9.50
- CELU $6.00
- AVG Volume (30 Days)
- SURG 144.2K
- CELU 65.2K
- Earning Date
- SURG 11-12-2025
- CELU 11-14-2025
- Dividend Yield
- SURG N/A
- CELU N/A
- EPS Growth
- SURG N/A
- CELU N/A
- EPS
- SURG N/A
- CELU N/A
- Revenue
- SURG $50,372,555.00
- CELU $40,578,000.00
- Revenue This Year
- SURG $20.20
- CELU N/A
- Revenue Next Year
- SURG $121.54
- CELU $76.00
- P/E Ratio
- SURG N/A
- CELU N/A
- Revenue Growth
- SURG N/A
- CELU N/A
- 52 Week Low
- SURG $1.05
- CELU $1.00
- 52 Week High
- SURG $3.47
- CELU $4.35
- Technical
- Relative Strength Index (RSI)
- SURG 34.80
- CELU 56.59
- Support Level
- SURG $1.85
- CELU $1.62
- Resistance Level
- SURG $2.01
- CELU $1.83
- Average True Range (ATR)
- SURG 0.22
- CELU 0.17
- MACD
- SURG -0.04
- CELU 0.05
- Stochastic Oscillator
- SURG 11.81
- CELU 60.76
About SURG SurgePays Inc.
Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; and Others. It generates the majority of its revenue from the Mobile Virtual Network Operators segment.
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.